Alefacept for Psoriasis

Seminars in Cutaneous Medicine and Surgery

Volumn 29, Issue 1, 2010, Pages 53-55

  Heffernan, Michael P ^a   Leonardi, Craig L ^a  

^a Central Dermatology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEFACEPT; CYCLOSPORIN; METHOTREXATE; PLACEBO; STEROID;

ABSCESS; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; ANGIONEUROTIC EDEMA; APPENDICITIS; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BASAL CELL CARCINOMA; CELLULITIS; CHOLECYSTITIS; CLINICAL TRIAL; CUTANEOUS T CELL LYMPHOMA; DOSAGE SCHEDULE COMPARISON; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG RESPONSE; DRUG SAFETY; DRUG WITHDRAWAL; FATTY LIVER; GASTROENTERITIS; HERPES SIMPLEX; HODGKIN DISEASE; HUMAN; IMMUNOGENICITY; INFECTION; INJECTION SITE BLEEDING; INJECTION SITE EDEMA; INJECTION SITE INFLAMMATION; INJECTION SITE MASS; INJECTION SITE PAIN; INJECTION SITE REACTION; LIVER FAILURE; LYMPHOCYTOPENIA; MELANOMA; MYCOSIS FUNGOIDES; NONHODGKIN LYMPHOMA; PHOTOTHERAPY; PNEUMONIA; PSORIASIS; PSORIASIS VULGARIS; REVIEW; SEPTIC SHOCK; SIDE EFFECT; SKIN CANCER; SOLID TUMOR; SQUAMOUS CELL CARCINOMA; TOXIC HEPATITIS; UNSPECIFIED SIDE EFFECT; URTICARIA; WOUND INFECTION;

DERMATOLOGIC AGENTS; HUMANS; PSORIASIS; RECOMBINANT FUSION PROTEINS;

EID: 77951574500     PISSN: 10855629     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sder.2010.03.002     Document Type: Review

References (17)

1. Alefacept package insert. http://www.astellas.us/docs/amevive.pdf Accessed January 27, 2010
2. Wong V.K., and Lebwohl M. The use of alefacept in the treatment of psoriasis. Skin Ther Lett 8 7 (2003) 1-2
3. Gribetz C.H., Blum R., Brady C., et al. An extended 16-week course of alefacept in the treatment of chronic plaque psoriasis. J Am Acad Dermatol 53 (2005) 73-75
4. Sweetser M.T., Woodworth J., Swan S., et al. Results of a randomized open-label crossover study of the bioequivalence of subcutaneous versus intramuscular administration of alefacept. Dermatol Online J 12 (2006) 1
5. Goffe B., Papp K., Gratton D., et al. An integrated analysis of thirteen trials summarizing the long-term safety of alefacept in psoriasis patients who have received up to nine courses of therapy. Clin Ther 27 (2005) 1912-1921
6. Koo J.Y., Bagel J., Sweetser M.T., et al. Alefacept in combination with ultraviolet B phototherapy for the treatment of chronic plaque psoriasis: Results from an open-label, multicenter study. J Drugs Dermatol 5 (2006) 623-628
7. Legat F.J., Hofer A., Wackernagel A., et al. Narrowband UV-B phototherapy, alefacept, and clearance of psoriasis. Arch Dermatol 143 (2007) 1016-1022
8. Magliocco M.A., Lozano A.M., Van Saders C., et al. An open-label study to evaluate the transition of patients with chronic plaque psoriasis from cyclosporine to alefacept. J Drugs Dermatol 6 (2007) 424-427
9. Lebwohl M., Christophers E., Langley R., et al. An international, randomized, double-blind, placebo-controlled phase 3 trial of intramuscular alefacept in patients with chronic plaque psoriasis. Arch Dermatol 139 (2003) 719-727
10. Krueger G.G., Papp K.A., Stough D.B., et al. A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis. J Am Acad Dermatol 47 (2002) 821-833
11. Notice of Canadian Agency for Drugs and Technologies in Health. CEDAC, Sept 27 2006
12. Menter A., Cather J.C., Baker D., et al. The efficacy of multiple courses of alefacept in patients with moderate to severe chronic plaque psoriasis. J Am Acad Dermatol 54 (2006) 61-63
13. Goffe B., Papp K., Gratton D., et al. An integrated analysis of thirteen trials summarizing the long-term safety of alefacept in psoriasis patients who have received up to nine courses of therapy. Clin Ther 29 (2005) 1912-1921
14. Graves J.E., Nunley K., and Heffernan M.P. Off-label uses of biologics in dermatology: Rituximab, omalizumab, infliximab, etanercept, adalimumab, efalizumab, and alefacept (part 2 of 2). J Am Acad Dermatol 56 (2007) e55-e79
15. Strober B.E., Menon K., McMichael A., et al. Alefacept for severe alopecia areata: A randomized, double-blind, placebo-controlled study. Arch Dermatol 145 (2009) 1262-1266
16. Stotler C.J., Eghtesad B., Hsi E., et al. Rapid resolution of GVHD after orthotopic liver transplantation in a patient treated with alefacept. Blood 113 (2009) 5365-5366
17. Scheinfeld N. Alefacept: Its safety profile, off-label uses, and potential as part of combination therapies for psoriasis. J Dermatol Treat 18 (2007) 197-208